Tag: Ulcerative Colitis
Researchers Find Biomarker Tied to Severity of Ulcerative Colitis
HLA-DRB1*01:03 allele linked to severe disease requiring hospitalization, major operation, systemic corticosteroid use
Anti-TL1A Monoclonal Antibody, Tulisokibart, Aids Ulcerative Colitis
In addition, genetic test may assist in identifying patients more likely to respond
FDA Approves Tremfya for Ulcerative Colitis
Approval is for adults with moderately to severely active disease
Persistent Fluorinated Chemicals Tied to Higher Risk for Inflammatory Bowel Disease
Odds for Crohn disease and ulcerative colitis increased with higher serum perfluoroalkyl and polyfluoroalkyl substance levels up to 10 years before diagnosis
Histologic Inflammation With IBD Tied to Serious Infections
Authors say achieving histologic remission for both Crohn disease and ulcerative colitis may reduce the risk for serious infections
Inflammatory Bowel Disease Increases Risk for Later Arrhythmias
Findings seen for inflammatory bowel disease overall, as well as individual diseases
FDA Approves Velsipity for Moderate-to-Severe Ulcerative Colitis in Adults
Significant benefits at 12 weeks include clinical remission, endoscopic improvement, mucosal healing
Lower Fiber Intake Tied to Higher Risk for Later Inflammatory Bowel Disease
Findings seen for Crohn disease, but not ulcerative colitis
Mirikizumab Tops Placebo for Moderately-to-Severely Active Ulcerative Colitis
Mirikizumab more effective for inducing and maintaining clinical remission in patients with ulcerative colitis
Small Increase in Lymphoma Risk Seen With Crohn Disease, Ulcerative Colitis
Hazard ratios highest for patients exposed to immunomodulators and biologics or second-line biologics
